Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis

Oncogene

Volumn 16, Issue 17, 1998, Pages 2243-2248

  Kondo, Yasuko ^a   Kondo, Seiji ^a   Tanaka, Yoshikazu ^b   Haqqi, Talat ^a   Barna, Barbara P ^c   Cowell, John K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cisplatin; Glioma; Telomerase

Indexed keywords

CISPLATIN; REPETITIVE DNA; TELOMERASE;

APOPTOSIS; ARTICLE; CELL DEATH; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032580369     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201754     Document Type: Article

References (39)

1. Andrew PA and Howell SB. (1990). Cancer Res., 2, 35-43.
2. Blackburn EH. (1991). Nature, 350, 569-573.
3. Broccoli D, Young JW and de Lange T. (1995). Proc. Natl. Acad. Sci. USA, 92, 9082-9086.
4. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S. (1995). Blood, 85, 2315-2320.
5. De Masters BK, Markham N, Lillehei KO and Shroyer KR. (1997). Am. J. Clin. Pathol., 107, 548-554.
6. Eastman A. (1990). Cancer Cells, 2, 275-280.
7. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B. (1995). Science, 269, 1236-1241.
8. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
9. Gately DP and Howell SB. (1993). Br. J. Cancer, 67, 1171-1176.
10. Greider CW and Blackburn EH. (1985). Cell, 43, 405-413.
11. Harley CB, Futcher AB and Greider CW. (1991). Nature, 345, 458-460.
12. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW. (1995a). J. Natl. Cancer Inst., 87, 895-902.
13. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek AP, Shay JW and Matsuura Y. (1995b). Cancer Res., 55, 3258-3262.
14. Hiyama E, Kodama T, Shiobara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T. (1997). Cancer Res., 57, 326-331.
15. Ikeda H, Nakano G, Nagashima K, Sakamoto K, Harasawa N, Kitamura T, Nakamura T and Nagamachi Y. (1987). Cancer Res., 47, 231-234.
16. Kato H, Araya S, Mukai S, Hirose K, Hashiramoto A, Yamada R, Fukui W, Ono K, Sano H and Kondo M. (1997). Proc. Japan Cancer Assoc., 56, 701.
17. Kaufman SH. (1989). Cancer Res., 49, 5870-5878.
18. Kawai K, Kamatani N, Georges E and Ling V. (1990). J. Biol. Chem., 265, 13137-13142.
19. Kelly SL and Rozencweig M. (1989). Eur. J. Clin. Oncol., 25, 1135-1140.
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW. (1994). Science, 266, 2011-2015.
21. Kondo S, Yin D, Morimura T, Kubo H, Nakatsu S and Takeuchi J. (1995a). Br. J. Cancer, 71, 282-289.
22. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A and Barnett GH. (1995b). Cancer Res., 55, 6166-6171.
23. Kondo S, Yin D, Morimura T and Takeuchi J. (1995c). J. Neurosurg., 82, 469-474.
24. Kondo S, Barnett GH, Hara H, Morimura T and Takeuchi J. (1995d). Oncogene, 10, 2001-2006.
25. Kondo S, Barna BP, Kondo Y, Tanaka Y, Cacey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werhel B and Barnett GH. (1996). Oncogene, 13, 1279-1285.
26. Langford LA, Piatyzek MA, Xu R, Schold SC and Shay JW. (1995). Lancet, 346, 1267-1268.
27. Lotem J and Sachs L. (1993). Cell Growth Diff., 4, 41-47.
28. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993a). Nature, 362, 847-849.
29. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993b). Cell, 74, 957-967.
30. Mandal M and Kumar R. (1997). J. Biol. Chem., 272, 14183-14187.
31. Onoda JM, Nelson KK, Taylor JD and Honn KV. (1989). Cancer Res., 49, 2844-2850.
32. Ozols RF, Cunnion RE, Klecker RW, Hamilton TC, Ostchega Y, Parrilo JE and Young RC. (1987). J. Clin. Oncol., 5, 641-647.
33. Perez RP, Hamilton TC and Ozols RF. (1990). Pharmacol. Ther., 48, 19-27.
34. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L and Reddel RR. (1995). Mol. Cell. Biol., 15, 4745-4753.
35. Sallinen P, Miettinen H, Sallinen SL, Haapasalo H, Helin H and Kohonen J. (1997). Am. J. Pathol., 150, 1159-1164.
36. Schoenberg BS. (1983). Walker MD, (ed.) (Nijhoff, Boston): 1-30.
37. Strahl C and Blackburn EH. (1996). Mol. Cell. Biol., 16, 53-65.
38. Timmer-Bosscha H, Hospers GAP, Meijer C, Mulder NH, Muskiet FAJ, Martini IA, Uges DRA and De Vries EGE. (1992). J. Natl. Cancer Inst., 81, 1069-1075.
39. Van Meir EG, Kikuchi T, Tada M, Li H, Diserens AC, Wojcik BE, Huang HJS, Friedmann T, de Tribolet N and Cavenee WK. (1994). Cancer Res., 54, 649-652.